MBCOF (Marvel Biosciences) Days Sales Outstanding: 0.00 (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MBCOF Marvel Biosciences Corp MBCOF
33 GF Score
Price $0.12
! 1 Warning Sign
View Full Analysis

What is Marvel Biosciences Days Sales Outstanding?

Marvel Biosciences MBCOF 33 Days Sales Outstanding is 0.00 as of Apr. 2026. GuruFocus rates MBCOF with a GF Score™ of 33/100. The stock has 1 warning sign investors should review. Among 838 Biotechnology companies, Marvel Biosciences ranks worse than 119331.62% on this metric.

Marvel Biosciences's average Accounts Receivable for the three months ended in Apr. 2026 was $0.00 Mil. Marvel Biosciences's Revenue for the three months ended in Apr. 2026 was $0.00 Mil.

The historical rank and industry rank for Marvel Biosciences's Days Sales Outstanding or its related term are showing as below:

MBCOF's Days Sales Outstanding is not ranked *
in the Biotechnology industry.
Industry Median: 69.12
* Ranked among companies with meaningful Days Sales Outstanding only.

Marvel Biosciences's Days Sales Outstanding stayed the same from Apr. 2025 (0.00) to Apr. 2026 (0.00).


Marvel Biosciences  (OTCPK:MBCOF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Marvel Biosciences Days Sales Outstanding Related Terms


Marvel Biosciences Days Sales Outstanding Historical Data

* Premium members only.

The historical data trend for Marvel Biosciences's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Marvel Biosciences Days Sales Outstanding Chart

Marvel Biosciences Annual Data
Trend Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Days Sales Outstanding
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Marvel Biosciences Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MBCOF vs VRTX, REGN, RVMD: Days Sales Outstanding Comparison

For the Biotechnology subindustry, Marvel Biosciences's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Marvel Biosciences Days Sales Outstanding vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Marvel Biosciences's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Marvel Biosciences's Days Sales Outstanding falls into.


MBCOF
33GF Score
Marvel Biosciences Corp MBCOF
Days Sales Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Marvel Biosciences Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Marvel Biosciences's Days Sales Outstanding for the fiscal year that ended in Jul. 2025 is calculated as

Days Sales Outstanding (A: Jul. 2025 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jul. 2024 ) + Accounts Receivable (A: Jul. 2025 )) / count ) / Revenue (A: Jul. 2025 )*Days in Period
=( (0 + 0) / 1 ) / 0*365
=0 / 0*365
=N/A

Marvel Biosciences's Days Sales Outstanding for the quarter that ended in Apr. 2026 is calculated as:

Days Sales Outstanding (Q: Apr. 2026 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jan. 2026 ) + Accounts Receivable (A: Apr. 2026 )) / count ) / Revenue (A: Apr. 2026 )*Days in Period
=( (0 + 0) / 1 ) / 0*365 / 4
=0 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Sales Outstanding →
What does a Days Sales Outstanding of 0.00 mean?
Marvel Biosciences (MBCOF) has a Days Sales Outstanding of 0.00 as of Apr. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Marvel Biosciences and its competitors. According to the industry distribution chart, Marvel Biosciences ranks #999999 out of 838 companies in the Biotechnology industry.
Is Marvel Biosciences' Days Sales Outstanding too high?
Marvel Biosciences' current Days Sales Outstanding is 0.00. Based on the distribution chart, Marvel Biosciences ranks #999999 out of 838 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Marvel Biosciences has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Marvel Biosciences' Days Sales Outstanding compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Marvel Biosciences ranks #999999 out of 838 companies for Days Sales Outstanding. This places Marvel Biosciences in the lower half of its industry. The industry median Days Sales Outstanding is 69.12. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Biotechnology company?
The median Days Sales Outstanding among Biotechnology companies is 69.12, based on 838 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Marvel Biosciences and its competitors. For the Biotechnology industry, the median Days Sales Outstanding is 69.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Marvel Biosciences's current Days Sales Outstanding is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Marvel Biosciences stock overvalued right now?
Marvel Biosciences (MBCOF) has a current Days Sales Outstanding of 0.00. The current Days Sales Outstanding is 0.00. Marvel Biosciences' overall GF Score™ is 33/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Marvel Biosciences (MBCOF), the current Days Sales Outstanding is 0.00 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Marvel Biosciences Business Description

Other Exchanges MRVL:Canada
Address 505 - 8th Avenue SW, Suite 420, Calgary, AB, CAN, T2P1G2
Marvel Biosciences Corp is a biotechnology company incorporated in Canada. The Company is currently a pre-clinical stage pharmaceutical development company that utilizes a drug redevelopment approach to identify and evaluate potential therapeutic compounds. Its activities mainly involve scientific research and pre-clinical studies aimed at determining viable active compounds for further drug development.
33GF Score

Get the complete analysis for MBCOF

Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.12
Price